ABVC BioPharma, Inc (ABVC) Provides 2023 Pipeline Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. RTX
6. COF
7. SMCI
8. GOOGL
9. TSLA
10. CRWV

Go back to ABVC BioPharma, Inc (ABVC) Provides 2023 Pipeline Update

ABVC BioPharma Provides 2023 Pipeline Update

February 28, 2023 8:30 AM EST

FREMONT, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today provided an update to drug and medical device developments expected in 2023.

Major Depressive Disorder:

ABVCs MDD medicine, ABV-1504, has successfully completed Phase II at the Stanford... More